Clinical Trials Sponsored by Zhejiang Putuo Hospital

Total 2072 results

Zhejiang Hospital
Zhejiang University

Unknown

Autologous Hematopoietic Stem Cell Transplantation in Ischemic Stroke (AHSCTIS)

Stroke

China
Shanghai University of Traditional Chinese Medicine
Longhua Hospital; Shanghai Putuo District Center Hospital

Completed

Traditional Chinese Medicine in Individualized Treatment of Patients With Diabetes Symptoms

Type 2 Diabetes Mellitus

China
Zhejiang Cancer Hospital

Recruiting

Genotype-driven Weekly Irinotecan Liposomes in Combination With Capecitabine-based Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer

Rectal Cancer

China
Zhejiang Cancer Hospital

Not yet recruiting

Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy

Adjuvant Radiotherapy

China
Zhejiang Cancer Hospital

Recruiting

Ciprofol EC50 for Inducing Loss of Consciousness in Elderly Patients

Elderly Patients

China
Zhejiang Cancer Hospital

Not yet recruiting

Clinical Study of Short-course Radiotherapy Followed by Fruquintinib Plus Sintilimab vs Bevacizumab Plus Capecitabine as First Line Treatment in Advanced mCRC

Metastatic Colorectal Cancer | Metastatic Colorectal Adenocarcinoma | CRC

China
Zhejiang Cancer Hospital

Recruiting

A Clinical Study of Sintilimab as Adjuvant Therapy in Node-positive ESCC

Esophageal Squamous Cell Carcinoma

China
Zhejiang Cancer Hospital

Recruiting

Postoperative Analgesia With Liposomal Bupivacaine Versus Standard Bupivacaine Combined With Dexamethasone

Liver Cancer

China
Zhejiang Cancer Hospital

Recruiting

Dalpiciclib Combination With Fulvestrant and Compound Gossyfol Acetate Tablets in Women With CDK4/6 Inhibitor-refractory HR-positive HER-2 Negtive Metastatic Breast Cancer: a Phase 2 Clinical Trial.

Advanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment Failed

China
Zhejiang Cancer Hospital

Recruiting

Surufatinib Plus Cadonilimab in Patients With Unresectable or Metastatic Bile Duct Adenocarcinoma

Bile Duct Adenocarcinoma

China
Zhejiang Cancer Hospital

Recruiting

A-RGEMOX in the Treatment of Early Relapsed/Refractory DLBCL

Diffuse Large B-cell Lymphoma Recurrent | Diffuse Large B Cell Lymphoma Refractory

China
Zhejiang Cancer Hospital

Recruiting

Gemcitabine Combined With Endostar and Envafolimab in Elderly Patients With Locally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Zhejiang Cancer Hospital

Recruiting

XPO-1 in Combination With RCHOP for DH/TH Lymphoma

Double Hit Lymphoma | Triple Hit Lymphoma

China
Zhejiang Cancer Hospital

Recruiting

Efficacy and Safety of Inetetamab Combined With Pyrotinib and Vinorelbine in ABC (HER2-VIP)

HER2-positive Advanced Breast Cancer

China
Zhejiang Cancer Hospital

Not yet recruiting

Camrelizumab Combined With Irinotecan or Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer

Second Line Treatment of Gastric Cancer
Zhejiang Cancer Hospital

Recruiting

DLCS for Predicting Neoadjuvant Chemotherapy Response

Gastric Cancer | Deep Learning | Neoadjuvant Chemotherapy | CT Images | Tumor Regression Grade

China
Zhejiang Cancer Hospital

Recruiting

A Single-Arm Phase II Exploratory Clinical Study of Pemigatinib in the Treatment of Advanced Gastrointestinal Cancer (Excluding Biliary Tract Cancer) Patients With FGFR Alterations Who Have Failed Standard Therapy

Gastrointestinal Cancer

China
Zhejiang Cancer Hospital

Recruiting

Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early Prediction of Chemosensitivity in Liver MBC (DreaminLMBC)

Metastatic Breast Cancer in the Liver

China
Zhejiang Cancer Hospital

Recruiting

TRT for ES-SCLC After First Line Treatment With Immune Checkpoint Inhibitors

SCLC,Extensive Stage

China
Zhejiang Cancer Hospital

Recruiting

SBRT for Oligoprogressive NSCLC After First Line Treatment With Immune Checkpoint Inhibitors

NSCLC Stage IV

China
Zhejiang Cancer Hospital

Not yet recruiting

Phase II Clinical Study of Camrelizumab Combined With Chemotherapy or Anlotinib in Advanced Esophageal Squamous Cell Cancer

Stage IV Esophagus Squamous Cell Carcinoma

China
Zhejiang Cancer Hospital

Recruiting

ZR2 Followed by Immunochemotherapy in Elderly Patients With Newly-diagnosed DLBCL

Diffuse Large B Cell Lymphoma

China
Zhejiang Cancer Hospital

Recruiting

The Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced Breast Cancer

Breast Neoplasm Female

China
Zhejiang Cancer Hospital

Not yet recruiting

RecurIndex Predicts Risk of Recurrence in Early-stage Luminal Breast Cancer

Recurrence | Breast Cancer
Zhejiang Cancer Hospital

Recruiting

Anlotinib to Malignant Brainstem Glioma

Glioma | Malignant Brain Stem Tumor

China
Zhejiang Cancer Hospital

Recruiting

Preliminary Efficacy Analysis of Cheng's Giraffe Reconstruction After Proximal Gastrectomy

Gastric Cancer | Reflux Esophagitis

China
Zhejiang Cancer Hospital

Recruiting

Clinical Study on the First-line Treatment of Advanced Biliary System Tumors With Tripley Monoclonal Antibody Combined With GEMOX Regimen

Advanced Biliary Tract Tumors

China
Zhejiang Cancer Hospital

Recruiting

Tegio Consolidation Therapy for NPC Patients With High Risk of Metastasis

Nasopharyngeal Carcinoma

China
Zhejiang Cancer Hospital

Recruiting

PET/MR in Locally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma | PET/MR

China
Zhejiang Cancer Hospital

Completed

Sintilimab Combined With Anlotinib in Advanced NSCLC With EGFR Uncommon Mutations

Lung Cancer

China
Zhejiang Cancer Hospital

Completed

Whether Dexmedetomidine Can Improve the Prognosis of Elderly Patients With Postoperative Cognitive Dysfunction

Postoperative Delirium | Postoperative Cognitive Dysfunction

China
Zhejiang Cancer Hospital

Completed

Effect of Propofol and Desflurane on Nucleic Acid of Liver Circulating Tumor

Hepatocellular Carcinoma | Circulating Tumor Cells | Desflurane Adverse Reaction | Propofol Adverse Reaction

China
Zhejiang Cancer Hospital

Completed

Anterior Quadratus Lumborum Block at the Lateral Supra-arcuate Ligament for Analgesia After Open Liver Surgery

Liver Surgery

China
Zhejiang Cancer Hospital

Completed

S-1 Concurrent With Radiotherapy Versus Radiotherapy for Elderly Patients With Esophageal Cancer

Esophageal Cancer | Chemoradiation

China
Zhejiang Cancer Hospital

Unknown

A Clinical Study of Exploring Camrelizumab in the Treatment of Colorectal Mucinous Adenocarcinoma(MAC)

Colorectal Cancer

China
Zhejiang Cancer Hospital

Unknown

Anlotinib in Combination With PD1 With Gemcitabine Plus(+)Cisplatin for Unresectable or Metastatic Biliary Tract Cancer

Biliary Tract Cancer

China
Zhejiang Cancer Hospital

Completed

Analysis of Driver Gene Mutation in Early Stage Non-small Cell Lung Cancer

Non-small Cell Lung Cancer
Zhejiang Cancer Hospital

Unknown

Recurrence Score-guiding Chemotherapy in Non-pCR HR Positive HER2 Negative Breast Cancer After Neoadjuvant Therapy (RSBNAT)

Breast Cancer
Zhejiang Cancer Hospital

Unknown

A Study of Sintilimab Plus Chemoradiation Before Surgery for Esophageal Cancer

Esophageal Squamous Cell Carcinoma

China
Zhejiang Cancer Hospital

Unknown

TACE Combined With Anlotinib Treatment of Middle-advanced Hepatocellular Carcinoma (HCC) Patients

Carcinoma, Hepatocellular

China
Zhejiang Cancer Hospital

Unknown

A Prospective Validation Cohort Study of a Prediction System on nSLN Metastasis in Early Breast Cancer

Breast Cancer | Lymph Node Metastases | Predictive Cancer Model

China
Zhejiang Cancer Hospital

Unknown

Prophylactic Use of PEG-rhG-CSF in Medium-high Risk of FN in Chemotherapy of Breast Cancer

Febrile Neutropenia
Zhejiang Cancer Hospital

Unknown

Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen at Least 2nd Line in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer

Breast Cancer

China
Zhejiang Cancer Hospital

Unknown

Predictive Factors of Acute Oral Mucositis Induced by Chemo-radiotherapy for Local Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Neoplasms | Stomatitis

China
Zhejiang Cancer Hospital

Unknown

A Phase II Trial of S-1 as Maintenance Treatment After Gemcitabine Plus Cisplatin Regimen Chemotherapy in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma.

Nasopharyngeal Carcinoma

China
Zhejiang Cancer Hospital

Unknown

Memory and MRI Changes With Hippocampus Avoidance Prophylactic Cranial Irradiation(HA-PCI) for Small Cell Lung Cancer(SCLC)

Small Cell Lung Cancer

China
Zhejiang Cancer Hospital

Unknown

Acquired Resistant Mechanism of the First-generation EGFR TKIs

Non-small Cell Lung Cancer | Aquired Resistance | EGFR TKIs

China
Zhejiang Cancer Hospital

Unknown

Thalidomide Plus Chemotherapy Versus Chemotherapy Alone for Advanced Breast Cancer

Metastatic Breast Cancer

China
Zhejiang Cancer Hospital

Unknown

Comparison of Lobectomy and Segmentectomy for cT1aN0M0 Peripheral NSCLC

Non-small Cell Lung Cancer

China
Zhejiang Cancer Hospital

Completed

Icotinib Combined With Whole Brain Radiotherapy in Treating Multiple Brain Metastases From Non-Small Cell Lung Cancer

Lung Cancer | Metastatic Cancer

China

3

Subscribe